Page last updated: 2024-08-21

diphenylamine and Triple Negative Breast Neoplasms

diphenylamine has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nan, XY; Wu, Y; Yang, ZJ; Zhang, LH	1

Other Studies

1 other study(ies) available for diphenylamine and Triple Negative Breast Neoplasms

Article	Year
[Treatment of triple negative breast cancer cells with combination of mTOR1/2 inhibitor AZD8055 and MEK1/2 inhibitor PD0325901]. Yao xue xue bao = Acta pharmaceutica Sinica, 2016, Volume: 51, Issue:10 Topics: Benzamides; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Morpholines; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms	2016

Article

Year

[Treatment of triple negative breast cancer cells with combination of mTOR1/2 inhibitor AZD8055 and MEK1/2 inhibitor PD0325901].

Yao xue xue bao = Acta pharmaceutica Sinica, 2016, Volume: 51, Issue:10

Topics: Benzamides; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Morpholines; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms

2016